Literature DB >> 15451463

Physical and infectious titers of helper-dependent adenoviral vectors: a method of direct comparison to the adenovirus reference material.

Donna J Palmer1, Philip Ng.   

Abstract

Accurate measurements of the physical and infectious titers of adenoviral vectors are crucial for evaluating preclinical studies and for the safety and efficacy of clinical studies. Unfortunately, there are no standardized methods of measurement, consequently variable and unreliable values are the result. Furthermore, infectious titers of helper-dependent adenoviral vectors (HDAd) are difficult to measure because traditional cytopathic effect assays cannot be employed, thus hindering their potential clinical application. In response to this problem, a fully characterized Adenovirus Reference Material (ARM) has been developed to be used as a reference standard for clinical grade adenoviral vectors. However, no specific protocols for this purpose have been provided. To fulfill this important need, we have developed a simple assay involving co-infection of 293 cells with the adenoviral vector and the ARM to permit direct comparisons of their physical and infectious titers. We demonstrate, using a HDAd, that this co-infection assay is reliable, sensitive, and reproducible. Importantly, this assay is inherently unaffected by variables that plague other methods of determining vector titers. This assay is applicable to all human serotype 5 adenoviral vectors and will permit reliable comparisons within and between studies as well as meet an important prerequisite for clinical studies.

Entities:  

Mesh:

Year:  2004        PMID: 15451463     DOI: 10.1016/j.ymthe.2004.06.1013

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  36 in total

1.  Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors.

Authors:  Emi Aizawa; Yuka Hirabayashi; Yuzuru Iwanaga; Keiichiro Suzuki; Kenji Sakurai; Miho Shimoji; Kazuhiro Aiba; Tamaki Wada; Norie Tooi; Eihachiro Kawase; Hirofumi Suemori; Norio Nakatsuji; Kohnosuke Mitani
Journal:  Mol Ther       Date:  2011-12-06       Impact factor: 11.454

2.  Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reaction.

Authors:  M Puntel; J F Curtin; J M Zirger; A K M Muhammad; W Xiong; C Liu; J Hu; K M Kroeger; P Czer; S Sciascia; S Mondkar; P R Lowenstein; M G Castro
Journal:  Hum Gene Ther       Date:  2006-05       Impact factor: 5.695

Review 3.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

4.  Correction of hyperbilirubinemia in gunn rats using clinically relevant low doses of helper-dependent adenoviral vectors.

Authors:  David Dimmock; Nicola Brunetti-Pierri; Donna J Palmer; Arthur L Beaudet; Philip Ng
Journal:  Hum Gene Ther       Date:  2011-02-16       Impact factor: 5.695

5.  A rapid protocol for construction and production of high-capacity adenoviral vectors.

Authors:  Lorenz Jager; Martin A Hausl; Christina Rauschhuber; Nicola M Wolf; Mark A Kay; Anja Ehrhardt
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

6.  Transgene expression up to 7 years in nonhuman primates following hepatic transduction with helper-dependent adenoviral vectors.

Authors:  Nicola Brunetti-Pierri; Thomas Ng; David Iannitti; William Cioffi; Gary Stapleton; Mark Law; John Breinholt; Donna Palmer; Nathan Grove; Karen Rice; Cassondra Bauer; Milton Finegold; Arthur Beaudet; Charles Mullins; Philip Ng
Journal:  Hum Gene Ther       Date:  2013-08       Impact factor: 5.695

7.  Large-scale production of high-quality helper-dependent adenoviral vectors using adherent cells in cell factories.

Authors:  Masataka Suzuki; Racel Cela; Christian Clarke; Terry K Bertin; Susana Mouriño; Brendan Lee
Journal:  Hum Gene Ther       Date:  2010-01       Impact factor: 5.695

8.  Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer.

Authors:  Reeti Khare; Shannon M May; Francesco Vetrini; Eric A Weaver; Donna Palmer; Amanda Rosewell; Nathan Grove; Philip Ng; Michael A Barry
Journal:  Mol Ther       Date:  2011-04-19       Impact factor: 11.454

9.  Phenotypic correction of ornithine transcarbamylase deficiency using low dose helper-dependent adenoviral vectors.

Authors:  Nicola Brunetti-Pierri; Christian Clarke; Viraj Mane; Donna J Palmer; Brendan Lanpher; Qin Sun; William O'Brien; Brendan Lee
Journal:  J Gene Med       Date:  2008-08       Impact factor: 4.565

10.  Efficient, long-term hepatic gene transfer using clinically relevant HDAd doses by balloon occlusion catheter delivery in nonhuman primates.

Authors:  Nicola Brunetti-Pierri; Gary E Stapleton; Mark Law; John Breinholt; Donna J Palmer; Yu Zuo; Nathan C Grove; Milton J Finegold; Karen Rice; Arthur L Beaudet; Charles E Mullins; Philip Ng
Journal:  Mol Ther       Date:  2008-12-02       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.